Free Trial

SCYNEXIS (SCYX) News Today

SCYNEXIS logo
$0.71 -0.02 (-3.23%)
As of 04:00 PM Eastern

SCYX Latest News

SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
Scynexis to present preclinical data on SCY-247 at ESCMID Meeting
SCYNEXIS Full Year 2024 Earnings: Misses Expectations
Maxim Group Keeps Their Buy Rating on SCYNEXIS (SCYX)
Federated Hermes, Inc. Expands Stake in SCYNEXIS Inc
Scynexis Inc
3 Stocks Under $10 With the Potential for Massive Gains
3 Stocks Under $10 With the Potential for Massive Gains
3 Dirt-Cheap Drug Developers With Blockbuster Potential
3 Stocks Under $10 With Mammoth Growth Prospects
SCYNEXIS, Inc. (SCYX)
Get SCYNEXIS News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCYX and its competitors with MarketBeat's FREE daily newsletter.

SCYX Media Mentions By Week

SCYX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SCYX
News Sentiment

0.00

0.57

Average
Medical
News Sentiment

SCYX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SCYX Articles
This Week

0

0

SCYX Articles
Average Week

Get SCYNEXIS News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCYX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SCYX) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners